Key result
Targeting oral anticoagulation requires precise clinical management to optimize therapeutic efficacy and minimize adverse events.
Key points are not available for this paper at this time.
Underscores need for vigilant monitoring in practice; leaves open optimal strategies for specific populations.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
M. Weiner (2000) studied this question. Targeting oral anticoagulation requires precise clinical management to optimize therapeutic efficacy and minimize adverse events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: